Stocks › LLY
Eli Lilly and Co LLY
US equityMarket cap rank #13
$1,354.00 −$10.73 (-0.79%)
Market closed · Nov 7, 9:50 pm ET · Last extended-hours $1,357.00 +0.22%
Open$1,350.45
Prev close$1,364.73
Day range$1,333.22 – $1,377.28
Volume3.81M
Market cap$1.27T
P/E (TTM)43.9
Dividend yield0.49%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$24.40B+38.6% YoY
Operating profit$13.09B+56.1% YoY
Net profit$6.45B+15.5% YoY
Diluted EPS$7.22+16.3% YoY
Free cash flow$4.16B-31.0% YoY
Operating cash flow$11.40B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin83.6%
Operating margin51.3%
Net margin31.9%
Return on equity86.1%
Return on assets21.0%
Return on invested capital35.3%
Current ratio1.39
Liabilities / assets72.8%
Cash & investments$4.89B
Total debt$49.50B
Net cash (debt)-$44.62B
Free cash flow / sales13.5%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $24.40B | $22.97B | $19.80B | $65.18B | $19.29B |
| Total Operating Revenue | $24.40B | $22.97B | $19.80B | $65.18B | $19.29B |
| Cost of Revenue | $3.93B | $3.27B | $3.58B | $11.05B | $3.37B |
| Gross Profit | $20.46B | $19.71B | $16.22B | $54.13B | $15.92B |
| Operating Expense | $7.37B | $7.25B | $6.44B | $24.43B | $6.93B |
| Selling and Admin Expenses | $3.13B | $3.43B | $2.93B | $11.09B | $3.13B |
| Research & Development | $4.25B | $3.82B | $3.51B | $13.34B | $3.80B |
| Operating Profit | $13.09B | $12.46B | $9.78B | $29.70B | $8.99B |
| Other Income (Expense) | -$4.69B | -$3.21B | -$928.00M | -$3.97B | -$722.00M |
| Special Income (Charges) | -$4.48B | -$3.48B | -$863.00M | -$3.39B | -$613.00M |
| -Less:Other Special Charges | $4.18B | $3.48B | $584.00M | $2.91B | $529.00M |
| -Less:Write Off | $303.00M | – | $279.00M | $484.00M | $84.00M |
| Other Non-Operating Income (Expenses) | -$202.00M | $269.00M | -$65.00M | -$571.00M | -$109.00M |
| Pretax Profit | $8.41B | $9.25B | $8.85B | $25.73B | $8.27B |
| Tax | $1.96B | $2.15B | $1.45B | $5.09B | $1.63B |
| Net Profit | $6.45B | $7.10B | $7.40B | $20.64B | $6.64B |
| Profit from Continuing Operations | $6.45B | $7.10B | $7.40B | $20.64B | $6.64B |
| Net Income to Parent Company | $6.45B | $7.10B | $7.40B | $20.64B | $6.64B |
| Net Income to Common Stockholders | $6.45B | $7.10B | $7.40B | $20.64B | $6.64B |
| Basic EPS | $7.23 | $7.95 | $8.27 | $23.00 | $7.42 |
| Diluted EPS | $7.22 | $7.94 | $8.26 | $22.95 | $7.39 |
| Dividend Per Share | $1.73 | $1.73 | $1.73 | $6.00 | $1.50 |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $2.91B | $528.80M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $148.07B | $142.28B | $116.58B | $112.48B | $112.48B |
| Total Current Assets | $65.26B | $64.67B | $54.84B | $55.63B | $55.63B |
| Cash and Cash Equivalents & Short-Term Investments | $4.89B | $8.95B | $5.28B | $7.27B | $7.27B |
| -Cash and Cash Equivalents | $4.89B | $8.95B | $5.28B | $7.27B | $7.27B |
| Receivables | $25.23B | $23.48B | $21.18B | $20.16B | $20.16B |
| -Accounts Receivable | $22.09B | $20.08B | $18.43B | $17.76B | $17.76B |
| -Other Receivables | $3.14B | $3.39B | $2.75B | $2.40B | $2.40B |
| Prepaid Assets | $16.86B | $15.37B | $13.63B | $14.32B | $14.32B |
| Inventory | $18.19B | $16.79B | $14.53B | $13.74B | $13.74B |
| Other Current Assets | $91.00M | $86.00M | $214.00M | $147.00M | $147.00M |
| Total Non-Current Assets | $82.81B | $77.61B | $61.74B | $56.85B | $56.85B |
| Net PPE | $32.19B | $29.29B | $26.54B | $24.67B | $24.67B |
| -Gross PPE | $45.56B | $42.39B | – | $37.23B | $37.23B |
| -Accumulated Depreciation | -$13.37B | -$13.10B | – | -$12.56B | -$12.56B |
| Investments and Advances | $4.01B | $3.86B | $3.12B | $2.80B | $2.80B |
| -Available for Sale Securities | $1.20B | $1.25B | $868.00M | $668.00M | $668.00M |
| -Long Term Equity Investment | $2.81B | $2.61B | $2.25B | $2.13B | $2.13B |
| Goodwill and Other Intangible Assets | $27.96B | $26.96B | $13.50B | $12.42B | $12.42B |
| -Goodwill | $9.87B | $8.85B | $6.13B | $5.90B | $5.90B |
| -Other Intangible Assets | $18.08B | $18.11B | $7.37B | $6.52B | $6.52B |
| Non-Current Deferred Assets | $10.96B | $10.03B | $11.35B | $9.96B | $9.96B |
| Other Non-Current Assets | $7.70B | $7.48B | $7.23B | $6.99B | $6.99B |
| Total Liabilities | $107.80B | $108.40B | $85.38B | $85.94B | $85.94B |
| Total Current Liabilities | $47.00B | $47.74B | $36.63B | $35.23B | $35.23B |
| Payables | $5.79B | $6.11B | $5.03B | $5.38B | $5.38B |
| -Accounts Payable | $5.79B | $6.11B | $5.03B | $5.38B | $5.38B |
| Current Accrued Expenses | $24.17B | $21.12B | $17.55B | $17.38B | $17.38B |
| Short-Term Debt and Capital Lease Obligation | $2.52B | $7.05B | $4.00B | $1.64B | $1.64B |
| -Current Debt | $2.52B | $7.05B | $4.00B | $1.64B | $1.64B |
| Other Current Liabilities | $12.22B | $11.66B | $8.70B | $8.46B | $8.46B |
| Total Non-Current Liabilities | $60.81B | $60.66B | $48.74B | $50.71B | $50.71B |
| Long Term Accounts Payable and Other Payables | $6.07B | $5.46B | $5.29B | $5.88B | $5.88B |
| Long Term Debt and Capital Lease Obligation | $46.99B | $47.86B | $39.37B | $40.87B | $40.87B |
| -Long Term Debt | $46.99B | $47.86B | $39.37B | $40.87B | $40.87B |
| Other Non-Current Liabilities | $7.75B | $7.34B | $4.09B | $3.97B | $3.97B |
| Total Equity | $40.27B | $33.88B | $31.20B | $26.54B | $26.54B |
| Stockholders' Equity | $40.27B | $33.88B | $31.20B | $26.54B | $26.54B |
| Capital Stock | $588.00M | $588.00M | $590.00M | $590.00M | $590.00M |
| -Common Stock | $588.00M | $588.00M | $590.00M | $590.00M | $590.00M |
| Additional Paid-In Capital | $7.31B | $7.12B | $6.92B | $7.35B | $7.35B |
| Retained Earnings | $37.97B | $31.89B | $29.51B | $24.47B | $24.47B |
| Gains/Losses Not Affecting Retained Earnings | -$2.63B | -$2.76B | -$2.83B | -$2.88B | -$2.88B |
| Other Equity Interests | -$2.97B | -$2.96B | -$2.99B | -$2.99B | -$2.99B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $11.40B | $10.69B | $5.33B | $16.81B | $3.23B |
| Net cash flow from continuing operations | $11.40B | $10.69B | $5.33B | $16.81B | $3.23B |
| Net Income from Continuing Operations | $6.45B | $7.10B | $7.40B | $20.64B | $6.64B |
| Depreciation & Depletion & Amortization | $545.00M | $534.00M | $509.00M | $2.00B | $586.00M |
| Deferred Tax | -$665.00M | $1.05B | -$1.48B | -$1.71B | -$748.00M |
| Other Non-Cash Items | $4.43B | $2.49B | $409.00M | $3.53B | $467.00M |
| Change in Working Capital | $435.00M | -$670.00M | -$1.66B | -$8.09B | -$3.67B |
| Net cash flow from investing | -$8.30B | -$15.40B | -$3.92B | -$10.97B | -$2.80B |
| Net Cash Flow from Continuing Investing Activities | -$8.30B | -$15.40B | -$3.92B | -$10.97B | -$2.80B |
| Net PPE Purchase and Sale | -$3.18B | -$2.93B | -$2.33B | -$7.84B | -$2.55B |
| Net Intangibles Purchase and Sale | -$4.06B | -$3.28B | -$204.00M | -$2.79B | -$206.00M |
| Net Business Purchase and Sale | -$887.00M | -$8.75B | -$1.06B | -$661.00M | -$112.00M |
| Net Investment Purchase and Sale | -$258.00M | -$307.00M | -$297.00M | $319.00M | $837.00M |
| Net Other Investing Changes | $86.00M | -$127.00M | -$31.00M | $1.00M | -$775.00M |
| Financing Cash Flow | -$7.22B | $8.43B | -$3.47B | -$2.21B | -$2.88B |
| Net Cash Flow from Continuing Financing Activities | -$7.22B | $8.43B | -$3.47B | -$2.21B | -$2.88B |
| Net Issuance Payments Of Debt | -$5.28B | $11.58B | $1.03B | $8.05B | $0.00 |
| Net Common Stock Issuance | -$377.00M | -$1.60B | -$2.36B | -$4.11B | -$1.51B |
| Cash Dividends Paid | -$1.54B | -$1.55B | -$1.55B | -$5.38B | -$1.35B |
| Net Other Financing Charges | -$17.00M | -$4.00M | -$591.00M | -$772.00M | -$26.00M |
| Ending Cash Balance | $4.89B | $8.95B | $5.28B | $7.27B | $7.27B |
| Net Change in Cash | -$4.12B | $3.72B | -$2.05B | $3.63B | -$2.46B |
| Beginning Cash Balance | $8.95B | $5.28B | $7.27B | $3.27B | $9.79B |
| Effect of Exchange Rate Changes | $56.00M | -$52.00M | $67.00M | $372.00M | -$67.00M |
| Free Cash Flow | $4.16B | $4.48B | $2.80B | $5.96B | $254.00M |
| Gain/Loss from Continuing Operations | – | – | – | -$180.00M | – |
| -Change in Receivables | – | – | – | -$7.00B | – |
| -Change in Inventory | – | – | – | -$4.67B | – |
| -Change in Prepaid Assets | – | – | – | -$6.61B | – |
| -Change in Payables and Accrued Expense | – | – | – | $10.19B | – |
No comments yet — be the first to weigh in on LLY.
Sign in to join the discussion.